NasdaqGM - Nasdaq Real Time Price USD

United-Guardian, Inc. (UG)

Compare
9.05
0.00
(0.00%)
As of April 2 at 4:00:00 PM EDT. Market Open.
Loading Chart for UG
  • Previous Close 9.05
  • Open 9.26
  • Bid --
  • Ask --
  • Day's Range 9.05 - 9.05
  • 52 Week Range 7.35 - 16.25
  • Volume 156
  • Avg. Volume 8,316
  • Market Cap (intraday) 41.579M
  • Beta (5Y Monthly) 0.83
  • PE Ratio (TTM) 12.75
  • EPS (TTM) 0.71
  • Earnings Date May 8, 2025 - May 12, 2025
  • Forward Dividend & Yield 0.70 (7.73%)
  • Ex-Dividend Date Feb 10, 2025
  • 1y Target Est --

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

www.u-g.com

24

Full Time Employees

December 31

Fiscal Year Ends

Recent News: UG

View More

Performance Overview: UG

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

UG
2.28%
S&P 500 (^GSPC)
7.32%

1-Year Return

UG
20.75%
S&P 500 (^GSPC)
4.59%

3-Year Return

UG
53.91%
S&P 500 (^GSPC)
19.91%

5-Year Return

UG
10.97%
S&P 500 (^GSPC)
119.03%

Compare To: UG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UG

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    41.58M

  • Enterprise Value

    32.18M

  • Trailing P/E

    12.75

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.41

  • Price/Book (mrq)

    3.50

  • Enterprise Value/Revenue

    2.64

  • Enterprise Value/EBITDA

    8.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.69%

  • Return on Assets (ttm)

    17.06%

  • Return on Equity (ttm)

    27.94%

  • Revenue (ttm)

    12.18M

  • Net Income Avi to Common (ttm)

    3.25M

  • Diluted EPS (ttm)

    0.71

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.4M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.21M

Research Analysis: UG

View More

Company Insights: UG

Research Reports: UG

View More

People Also Watch